Rupert McShane

Also affiliated with Warneford Hospital, University of Oxford

MedicineNeuroscienceEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Development of the Ketamine Side Effect Tool (KSET)”.

Development of the Ketamine Side Effect Tool (KSET)

Journal of Affective Disorders(2020)10.1016/j.jad.2020.01.120

N/A

0DataRank · unranked

49 citations

Vanessa Dong, Verònica Gálvez, Vedran Vulovic, Donel Martin, Adam Bayes +11 more

Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT

Efficacy and Mechanism Evaluation(2020)10.3310/eme07020

N/A

0DataRank · unranked

18 citations

Olga Zubko, Richard Gray, Rosie Bradley, Emma Harper, Linda Kelly +16 more

The Ketamine Side Effect Tool (KSET): A comprehensive measurement-based safety tool for ketamine treatment in psychiatry

Journal of Affective Disorders(2022)10.1016/j.jad.2022.04.020

N/A

0DataRank · unranked

21 citations

Brooke Short, Carlos A. Zarate, Lawrence Park, James W. Murrough, Declan M. McLoughlin +13 more